Chi‐Feng Chang
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- Plant tissue culture and regeneration 2
-
- Head and Neck Cancer Studies 4
- Co-authors
- Huei‐Jen Wang (6 shared papers)Cathie Martin (2 shared papers)Nicola Stacey (2 shared papers)Kitty A. Plaskitt (2 shared papers)Adrian Parr (2 shared papers)Ángel Mérida (2 shared papers)Yu‐Ligh Liou (4 shared papers)David G. Lynn (1 shared paper)
- Journals
- Clinical Epigenetics (2 papers)Oral Oncology (2 papers)The Plant Cell (2 papers)Pharmacogenomics (1 paper)Alzheimer s & Dementia (1 paper)
- Partner nations
- TaiwanUnited StatesItaly
In The Last Decade
Chi‐Feng Chang
13 papers receiving 463 citations
Peers
Comparison fields: 5 of 64
- Otorhinolaryngology 36
- Cancer Research 90
- Periodontics 27
- Biochemistry 34
- Molecular Biology 345
Countries citing papers authored by Chi‐Feng Chang
This map shows the geographic impact of Chi‐Feng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Feng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Feng Chang more than expected).
Fields of papers citing papers by Chi‐Feng Chang
This network shows the impact of papers produced by Chi‐Feng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Feng Chang. The network helps show where Chi‐Feng Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Feng Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 174 | |
| 2 | 2014 | 62 | |
| 3 | 2016 | 43 | |
| 4 | 2017 | 40 | |
| 5 | 2016 | 37 | |
| 6 | 2021 | 33 | |
| 7 | 2015 | 29 | |
| 8 | 2017 | 22 | |
| 9 | 2009 | 14 | |
| 10 | 1998 | 13 | |
| 11 | 2018 | 5 | |
| 12 | 2011 | 3 | |
| 13 | 2021 | 2 |
About Chi‐Feng Chang
Chi‐Feng Chang is a scholar working on Molecular Biology, Otorhinolaryngology, Epidemiology, Oncology and Periodontics, having authored 13 papers that have together received 477 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (4 papers), Head and Neck Cancer Studies (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (2 papers), Oral Health Pathology and Treatment (2 papers), Cancer-related molecular mechanisms research (2 papers), Plant tissue culture and regeneration (2 papers) and Plant Pathogens and Fungal Diseases (1 paper). The work is most often cited by research in Otorhinolaryngology (36 citations), Cancer Research (90 citations), Periodontics (27 citations), Biochemistry (34 citations) and Molecular Biology (345 citations). Chi‐Feng Chang has collaborated with scholars based in Taiwan, United States and Italy. Frequent co-authors include Huei‐Jen Wang, Cathie Martin, Nicola Stacey, Kitty A. Plaskitt, Adrian Parr, Ángel Mérida, Yu‐Ligh Liou, David G. Lynn, Keith Roberts and J. Maxwell Dow. Their work appears in journals such as Clinical Epigenetics, Oral Oncology, The Plant Cell, Pharmacogenomics and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.